Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Predrag Sikiric

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Current Pharmaceutical Design|February 24, 2017
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Behavioural Brain Research|September 21, 2020
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophreniaAndrea Zemba Cilic, Mladen Zemba, Matija Cilic, et al.
European Journal of Pharmacology|August 12, 2019
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAMEMario Sucic, Kresimir Luetic, Ivan Jandric, et al.
Life Sciences|August 12, 2017
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in ratsDean Strinic, Zeljka Belosic Halle, Kresimir Luetic, et al.
Surgery Today|August 24, 2007
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the ratTihomir Vuksic, Ivan Zoricic, Luka Brcic, et al.
Inflammopharmacology|November 14, 2015
BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combinationMladen Zemba, Andrea Zemba Cilic, Igor Balenovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-SystemPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Surgery Today|August 1, 2008
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the ratTomislav Novinscak, Luka Brcic, Mario Staresinic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Digestive Diseases and Sciences|December 19, 2008
Gastric pentadecapeptide BPC 157 and short bowel syndrome in ratsMarko Sever, Robert Klicek, Bozo Radic, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Current Pharmaceutical Design|February 24, 2017
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Behavioural Brain Research|September 21, 2020
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophreniaAndrea Zemba Cilic, Mladen Zemba, Matija Cilic, et al.
European Journal of Pharmacology|August 12, 2019
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAMEMario Sucic, Kresimir Luetic, Ivan Jandric, et al.
Life Sciences|August 12, 2017
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in ratsDean Strinic, Zeljka Belosic Halle, Kresimir Luetic, et al.
Surgery Today|August 24, 2007
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the ratTihomir Vuksic, Ivan Zoricic, Luka Brcic, et al.
Inflammopharmacology|November 14, 2015
BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combinationMladen Zemba, Andrea Zemba Cilic, Igor Balenovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-SystemPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Surgery Today|August 1, 2008
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the ratTomislav Novinscak, Luka Brcic, Mario Staresinic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Digestive Diseases and Sciences|December 19, 2008
Gastric pentadecapeptide BPC 157 and short bowel syndrome in ratsMarko Sever, Robert Klicek, Bozo Radic, et al.
Pageof 12